2011 News

A clinical study published in Nutrition Research shows individuals supplementing their diets with Pantesin®, a highly absorbable and biologically active form of Vitamin B5, significantly lowered their LDL cholesterol levels.

September 26, 2011 SupplySide West attendees interested in learning about the latest in heart health research are invited to attend an education session led by John Rumberger, M.D., Ph.D., FACC, Director of Cardiac Imaging at the Princeton Longevity Center on Thursday, October 13 from 10 a.m. - 10:50 a.m. in the Lido room 3005.

July 14, 2011 In a sponsored podcast interview with peer-reviewed Natural Medicine Journal, University of Utah Brain Institute researcher Deborah Yurgelun-Todd, Ph.D., discusses the cognitive health benefits of Cognizin® Citicoline, as well as describes her most recent research, including new data presented at the New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, organized by the American Society of Clinical Psychopharmacology and the National Institutes of Health.

July 1, 2011 Kyowa Hakko Bio Co., Ltd, confirmed today it is implementing a global 10 percent price increase on all new business for all company products, due to rising corn and fuel prices worldwide. That includes products sold by Kyowa Hakko USA.

June 14, 2011 Distractions are an inevitable result of a wired, work-anywhere world, and research has shown that tuning out competing stimuli to focus on a task helps with tackling our increasingly long to-do lists. Fortunately, focus and attention are two areas that can be improved through nutrition, according to new research being presented by members of the University of Utah Brain Institute this week.

May 16, 2011 New York, NY – Research conducted at the University of Utah Brain Institute revealed that individuals receiving Cognizin(R) Citicoline at a dose of 250 mg showed improved attention and a better ability to produce correct responses in performance testing. Participants who were administered either the 250 mg or the 500 mg dose of Cognizin produced nearly identical results when compared to the placebo group, confirming that 250 mg is an efficacious dose for producing improvements in attention.

April 18, 2011 Kyowa Hakko USA today announced that Mary Murphy has been named Southeastern sales manager. In this position, Murphy will be charged with supporting and expanding Kyowa Hakko USA's strong position with customers in the Southeast, as well as growing the company's customer base within the region.

April 11, 2011 New York, NY – It is widely known in medical and nutrition circles that glutathione is the body’s master antioxidant because it is found in every cell and is crucial for detoxification, immune support and fighting free radicals. In a podcast interview with peer-reviewed Natural Medicine Journal, naturopathic physician Lise Alschuler, N.D., confirms that this crucial antioxidant can be absorbed orally as a supplement.

April 4, 2011 New York, NY – Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, will present scientific data on Kyowa Hakko's branded brain health ingredient Cognizin(R) at the SupplySide Science Tour held April 12, 2011, in Salt Lake City, UT. She will highlight results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.

March 22, 2011 Cognizin® Citicoline, a brain health ingredient from Kyowa Hakko USA, has received the 2010 Frost & Sullivan "Product Differentiation Excellence" award in the cognitive health ingredients category for its brain-supporting properties proven through relevant science and increasing market popularity.